BGNE - Beigene, Ltd. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - BGNE (1651308)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
39 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P2+1-1-8+0
S10-0-1-3+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

DM
2018-11-08
BGNEPeterson Amy C.CMO, Immuno-oncologyS - Sale+OE$120.20-40,000194,569-17%-$4,808,089
2018-09-04
BGNEHuang JaneCMO, HematologyS - Sale$174.59-2,911271,621-1%-$508,247
M
2018-08-29
BGNEGlazer Donald W.DirS - Sale$179.00-2,0004,188,4840%-$358,000
2018-08-23
BGNEPeterson Amy C.CMO, Immuno-oncologyS - Sale$169.12-5,769194,569-3%-$975,666
2018-08-13
BGNEWang XiaodongDirS - Sale$158.77-3,44913,152,9790%-$547,591
2018-08-02
BGNEBaker Bros. Advisors LPDir, 10%P - Purchase$108.00+5,814,10017,224,519+51%+$627,922,800
2018-07-16
BGNEOyler JohnCEO, 10%S - Sale$164.12-2,55065,347,5910%-$418,497
DM
2018-03-16
BGNELiang HowardCFO, Chief Strategy OfficerS - Sale+OE$160.27-40,0005,000-89%-$6,410,651
M
2018-02-28
BGNEOyler JohnCEO, 10%S - Sale$145.63-99,00064,617,5370%-$14,416,931
D
2018-02-28
BGNELi JiEVP, Gl. Head of Bus. Dev.S - Sale+OE$146.88-10,000475,000-2%-$1,468,760
2018-01-18
BGNEBaker Bros. Advisors LPDir, 10%P - Purchase$101.00+1,980,19884,830,765+2%+$199,999,998
2017-12-26
BGNEOyler JohnCEO, 10%S - Sale$96.47-20,13763,299,5500%-$1,942,515
D
2017-12-21
BGNEHuang JaneCMO, HematologyS - Sale+OE$98.00-1,000264,9000%-$98,000
D
2017-12-13
BGNEHuang JaneCMO, HematologyS - Sale+OE$94.25-1,500264,900-1%-$141,381
M
2017-12-06
BGNEOyler JohnCEO, 10%S - Sale$93.95-144,00063,319,6870%-$13,529,286
2017-12-04
BGNEHuang JaneCMO, HematologyS - Sale$86.00-1,100264,9000%-$94,600
M
2017-11-27
BGNEOyler JohnCEO, 10%S - Sale$84.66-85,90663,463,6870%-$7,272,904
M
2017-11-16
BGNEHuang JaneCMO, HematologyS - Sale$86.25-1,600266,000-1%-$138,000
M
2017-11-13
BGNEOyler JohnCEO, 10%S - Sale$80.50-150,95763,549,5930%-$12,152,374
2017-11-13
BGNEPeterson Amy C.CMO, Immuno-oncologyS - Sale$82.96-3,601225,002-2%-$298,747
2017-08-11
BGNEBaker Bros. Advisors LPDir, 10%P - Purchase$71.00+176,05683,811,0130%+$12,499,976
2017-07-12
BGNEWang XiaodongDirS - Sale$72.44-20,00012,739,9240%-$1,448,704
2017-07-10
BGNEGlazer Donald W.DirS - Sale$72.15-10,8104,565,7940%-$779,900
2017-07-06
BGNEOyler JohnCEO, 10%S - Sale$64.82-219,40069,185,5500%-$14,221,125
2017-06-28
BGNEWang XiaodongDirS - Sale$44.95-35,00012,759,9240%-$1,573,345
M
2017-06-22
BGNEOyler JohnCEO, 10%S - Sale$44.16-98,50071,475,6700%-$4,349,622
2017-06-02
BGNEWang XiaodongDirS - Sale$40.00-5,53912,785,0830%-$221,560
M
2017-05-03
BGNEWang XiaodongDirS - Sale$40.80-14,46112,800,4630%-$590,042-2-6
M
2017-04-27
BGNEOyler JohnCEO, 10%S - Sale$40.47-36,14971,574,1700%-$1,462,8080-3
2017-04-05
BGNEWang XiaodongDirS - Sale$36.83-11,65012,814,9240%-$429,085+2+2+4
M
2017-03-22
BGNEWang XiaodongDirS - Sale$36.96-38,10712,826,5740%-$1,408,6120+1+4
M
2017-03-16
BGNEOyler JohnCEO, 10%S - Sale$39.39-31,98971,610,3190%-$1,260,073-4-8-7
M
2017-03-08
BGNEWang XiaodongDirS - Sale$39.89-36,89212,864,6810%-$1,471,756-1-2-7
M
2017-03-02
BGNEOyler JohnCEO, 10%S - Sale$40.91-108,99973,059,2950%-$4,459,330-10-8
M
2017-02-23
BGNEWang XiaodongDirS - Sale$38.19-38,35112,901,5730%-$1,464,793+2+7-5
M
2017-02-16
BGNEOyler JohnCEO, 10%S - Sale$40.55-64,96373,168,2940%-$2,634,0110-4-4
2016-11-23
BGNEWang XiaodongDirS - Sale$32.00-93,75015,339,924-1%-$3,000,000+20-4
2016-11-23
BGNEMalley ThomasDirP - Purchase$32.00+30,00030,000New+$960,000+20-4
2016-11-18
BGNEBaker Bros. Advisors LPDir, 10%P - Purchase$32.00+1,760,49583,652,734+2%+$56,335,8400-2-11
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top